TREX1 suppression imparts cancer-stem-cell-like characteristics to CD133 - osteosarcoma cells through the activation of E2F4 signaling.

International journal of clinical and experimental pathology(2019)

引用 27|浏览7
暂无评分
摘要
There is ongoing debate whether cancer stem cells (CSCs) could arise from the transformation of non-CSCs under specific conditions. In the present study, the role of the three prime repair exonuclease 1 (TREX1) in regulating CSC generation form human osteosarcoma cells was investigated. High, intermediate and low levels of TREX1 expression were respectively observed in low-grade, high-grade and metastatic human osteosarcoma samples, while the opposite tendency was observed for E2F4, a transcription factor associated with G2 arrest. Luciferase assay proved that TREX1 had a negative impact on the activity of promoter. TREX1 was highly expressed in CD133 HOS cells (non-CSC osteosarcoma cells) compared to CD133 ones; whereas TREX1 knockdown endowed the CD133 non-CSCs with CSC-like characteristics relying on E2F4 activation, as demonstrated by enlarged proportion of the subset expressing CSC markers in flow cytometry analysis, enhanced self-renewal ability in osteosphere formation assay, increased metastasis capacity in migration and invasion assays, together with improved chemoresistance to cisplatin. Furthermore, TREX1 knockdown and subsequent E2F4 activation could promote the tumorigenicity of CD133 non-CSCs . With respect to underlying mechanisms, it was found that in CD133 HOS cells, TREX1 suppression would allow the activation of β-catenin signaling in the dependence of E2F4, thus possibly leading to the up-regulation of the transcription factor OCT4. These findings suggested that TREX1 was probably a negative regulator of CSC formation and hence worth to be further studied for developing new treatments in cancer therapies targeting CSCs.
更多
查看译文
关键词
E2F4,OCT4,TREX1,cancer stem cells (CSCs),osteosarcoma,β-catenin signaling
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要